Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System
Authors' conclusion
This study highlights that scientific evidence, therapeutic options, and professional guidance on female health-related aspects in T1D are insufficient to date. Further efforts are required to better inform people with T1D, as well as for health care professionals, researchers, medical device manufacturers, and regulatory bodies to better address female health needs in therapeutic advances.
Study context
- Population
- Women with T1D using personalized open-source automated insulin delivery (AID) systems
- Participants
- 12 women
- Outcome
- Perceived changes in glycemic levels and insulin requirements throughout the menstrual cycle and different phases of life
Methodological detailssemi-structured interviews, thematic analysis, inductive, hypothesis-generating approach
- Semi-structured interviews
- Thematic analysis
- Inductive, hypothesis-generating approach
Main finding
As reported in the abstract
- Participants reported significant differences between follicular phase, ovulation and luteal phase, and during puberty, pregnancy and menopause
- All participants reported increased comfort and safety since using AID, but still had to manually adjust therapy to their cycle
- Lack of information and awareness and limited guidance by health care providers frequently mentioned
- Despite individual adjustment strategies, achieving optimum outcomes still perceived as challenging
Original publication
Variability of Glycemic Outcomes and Insulin Requirements Throughout the Menstrual Cycle: A Qualitative Study on Women With Type 1 Diabetes Using an Open-Source Automated Insulin Delivery System. J Diabetes Sci Technol. Published 7 March 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →